Add Company
Join Now

Twentyeight-Seven Therapeutics (28-7) Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Twentyeight-Seven Therapeutics (28-7)'s estimated annual revenue is currently $3.4M per year.(i)
  • Twentyeight-Seven Therapeutics (28-7)'s estimated revenue per employee is $155,000

Employee Data

  • Twentyeight-Seven Therapeutics (28-7) has 22 Employees.(i)
  • Twentyeight-Seven Therapeutics (28-7) grew their employee count by -4% last year.

Twentyeight-Seven Therapeutics (28-7)'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Twentyeight-Seven Therapeutics (28-7)?

28-7 Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$3.4M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M22-4%N/A
#2
$3.4M249%N/A
#3
$4.1M24-4%N/A
#4
N/A24-23%N/A
#5
$4.7M254%N/A